期刊文献+

Fluvastatin protects against puromycin aminonucleoside-induced podocyte injury by inhibiting TRPC6

氟伐他汀通过抑制TRPC6保护嘌呤霉素氨基核苷诱导的足细胞损伤
原文传递
导出
摘要 In the present study,we aimed to investigate the effect of puromycin aminonucleoside(PAN)on the expression and distribution of transient receptor potential canonical 6(TRPC6)of murine podocytes and further study the protective mechanism of fluvastatin on podocyte injury by TRPC6 in vitro.Podocytes were treated by PAN at different doses and at different time points.The expressions of TRPC6 at mRNA and protein levels were assessed.An immunofluorescent assay was used to observe the distribution of TRPC6.Cultured podocytes were then divided into four groups.The expressions of TRPC6 at mRNA and protein levels were measured.The intracellular calcium concentration of podocytes was measured with a laser-scanning confocal microscope.The paracellular permeability to BSA was evaluated using Millicell-PCF Inserts.The expressions of TRPC6 at mRNA and protein levels were increased in a dose and time-dependent manner after exposure to PAN.Immunofluorescence showed that the expression intensity of TRPC6 was significantly increased,and the distribution of TRPC6 was changed after PAN was applied to podocytes.With fluvastatin intervention,PAN-induced up-regulation of TRPC6 was significantly reversed.The ratio of the peak value of intracellular calcium to the basic calcium value in the PAN group was significantly higher after TRPC6 was activated by OAG,while it is obviously reversed under the action of fluvastatin.The podocyte permeability was significantly increased after 48 h of PAN treatment,while the above situation was effectively improved after fluvastatin intervention.The changes of distribution and expression of TRPC6 were related to podocyte injury induced by PAN.Fluvastatin could exert its protective effects on podocytes by down-regulating TRPC6. 在本研究中,我们观察了嘌呤霉素氨基核苷(PAN)对小鼠足细胞瞬时受体电位阳离子通道蛋白6(TRPC6)表达和分布的影响,并进一步研究了氟伐他汀对TRPC6所致足细胞损伤的保护机制。PAN在不同剂量和不同时间点处理足细胞,在mRNA和蛋白质水平上评估TRPC6的表达,免疫荧光法观察TRPC6的分布。然后再将体外培养的足细胞分为4组,分别检测TRPC6在mRNA和蛋白水平表达的变化,用激光共聚焦显微镜测定足细胞内钙浓度的变化,应用Millicell PCF评估BSA的细胞通透性。暴露于PAN后,TRPC6在mRNA和蛋白质水平的表达以剂量和时间依赖性方式增加。免疫荧光显示,将PAN应用于足细胞后,TRPC6的表达强度显著增加,并且TRPC6的分布发生改变。在氟伐他汀干预下,PAN诱导的TRPC6上调得以显著逆转。OAG激活TRPC6后,PAN组细胞内钙峰值与基础钙值的比值显著升高,而在氟伐他汀作用下则明显逆转。PAN处理48 h后足细胞通透性显著增加,而氟伐他汀干预后上述情况得到有效改善。TRPC6的分布和表达变化与PAN诱导足细胞损伤有关,氟伐他汀可通过下调TRPC6对足细胞发挥保护作用。
作者 Hui Gao Yunjing Zhang Jing Lin Xifeng Sun 高慧;张云静;林静;孙希锋(淄博市中心医院泌尿外科,山东淄博255036;淄博市中心医院肾内科,山东淄博255036;陕西省人民医院心内科,陕西西安710068)
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2022年第5期360-368,共9页 中国药学(英文版)
基金 National Natural Science Foundation of China(Grant No.81400333)。
关键词 TRPC6 PODOCYTE Puromycin aminonucleoside FLUVASTATIN CALCIUM 瞬时受体单位阳离子通道蛋白6 足细胞 嘌呤霉素氨基核苷 氟伐他汀 钙离子
  • 相关文献

参考文献3

二级参考文献43

  • 1张春,姜华军,常莹,朱忠华,刘建社,邓安国.敲低CD2AP基因表达对足细胞增殖和分裂的影响[J].中华肾脏病杂志,2007,23(12):778-783. 被引量:6
  • 2Lan HY.Diverse roles of TGF-β/Smads in renal fibrosis and inflammation[J].Int J Biol Sci,2011,7(7):1056-1067.
  • 3Lee SB,Kanasaki K,Kalluri R.Circulating TGFbeta1 as a reliable biomarker for chronic kidney disease progression in the African-American population[J].Kidney Int,2009,76(1):10-12.
  • 4Hills CE,Squires PE.The role of TGF-βand epithelial-to mesenchymal transition in diabetic nephropathy[J].Cytokine Growth Factor Rev,2011,22(3):131-139.
  • 5She S,Liu W,Li T,Hong Y.Effects of puerarin in STZ-induced diabetic rats by oxidative stress and the TGF-β1/Smad2 pathway[J].Food Funct,2014,5(5):944-950.
  • 6Hills CE,Squires PE.TGF-beta1-induced epithelialto-mesenchymal transition and therapeutic intervention in diabetic nephropathy[J].Am J Nephrol,2010,31(1):68-74.
  • 7Brennan EP,Morine MJ,Walsh DW,Roxburgh SA,Lindenmeyer MT,Brazil DP,et al.Next-generation sequencing identifies TGF-β1-associated gene expression profiles in renal epithelial cells reiterated in human diabetic nephropathy[J].Biochem Biophys Acta,2012,1822(4):589-599.
  • 8Lan HY,Chung AC.Transforming growth factor-βand Smads[J].Contrib Nephrol,2011,170:75-82.
  • 9Meng XM,Tang PM,Li J,Lan HY.TGF-β/Smad signaling in renal fibrosis[J].Front Physiol,2015,6:82.
  • 10Chung AC,Zhang H,Kong YZ,Tan JJ,Huang XR,Kopp JB,et al.Advanced glycation endproducts induce tubular CTGF via TGF-beta-independent Smad3 signaling[J].J Am Soc Nephrol,2010,21(2):249-260.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部